drugset / Trial / NCT00768690

A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of ABT-333

NCT00768690 ↗

Phase 1 Completed 45 enrolled Abbott
RandomizedSingle-groupTriple-blind

Summary

The purpose of this study is to determine multiple dose safety, tolerability and pharmacokinetics of ABT-333 under nonfasting conditions in healthy adult subjects, and to determine the effect of single dose administration of ketoconazole on steady state ABT-333 pharmacokinetics

Timeline

Start
2008-10
Primary completion
2009-02
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketoconazole Small molecule 400 mg —
Subject dasabuvir Small molecule 200 mg —
Subject dasabuvir Small molecule 400 mg —
Subject dasabuvir Small molecule 600 mg —
Subject dasabuvir Small molecule 1000 mg —